NCT05256342View on ClinicalTrials.gov

Biomarkers for Prediction of Analgesic Efficacy in Knee OA.

NACompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

December 30, 2021

Primary Completion Date

April 7, 2024

Study Completion Date

April 8, 2024

Conditions
Knee, Osteoarthritis (OA)Biomarkers for Prediction of OA Treatment Efficacy
Interventions
DRUG

Duloxetine 60mg

"Eight weeks treatment, one pill daily.~1st week 30mg; weeks 2-7th -- 60 mg daily."

DRUG

Etoricoxib 60 mg

One pill daily for 8 weeks

DRUG

omeprazol

20 mg daily; will be taken with Etoricoxib from the second week of treatment

Trial Locations (2)

31096

Rambam Health Care Campus, Haifa

Unknown

Rambam Health Care Campus, Haifa

All Listed Sponsors
lead

Rambam Health Care Campus

OTHER

NCT05256342 - Biomarkers for Prediction of Analgesic Efficacy in Knee OA. | Biotech Hunter | Biotech Hunter